Too much processed meat and not enough fruits and whole grains are the leading risk factors for diet-related GI cancers.

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

Researchers investigated immune-related adverse effects and characteristics that may predict their incidence in patients receiving ICIs for gastrointestinal cancers.

Researchers explored the link between cancer stage at diagnosis and survival outcomes for non-Hispanic Black patients with gastrointestinal cancers.

David B. Zhen, MD, discusses the results of the phase 3 CheckMate 649 trial in patients with advanced gastric cancer, ...

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...

Opdivo plus chemo showed long-term survival advantages in Chinese patients with advanced gastric, gastroesophageal junction ...

In 2024, 6,889 cancer patients visited the institute, up from around 3,500 in 2020, with majority suffering from ...

UC Davis Health, a university hospital in Sacramento, California, has become the first customer to order the EndoDrill GI ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...

A study showed Cabometyx improved time before disease progression in advanced digestive NETs compared with placebo.